Evidence map›Paper›PMID 21811636›Full record

ArticlePloS one2011

Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression.

Marta Miró-Murillo, Ainara Elorza, Inés Soro-Arnáiz, Lucas Albacete-Albacete, Angel Ordoñez, Eduardo Balsa, Alicia Vara-Vega, Silvia Vázquez, Esther Fuertes, Carmen Fernández-Criado and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Erythropoietin and Skeletal Cells CrossTalks in Physiology and Disease.Current opinion in endocrine and metabolic research · 2023
    Article
  4. Article
  5. Review
  6. Induction of whole-body gene deletionFrontiers in pharmacology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Marta Miró-MurilloAnimal Facility, Autonomous University of Madrid, Madrid, Spain.
Ainara Elorza
Inés Soro-Arnáiz
Lucas Albacete-Albacete
Angel Ordoñez
Eduardo Balsa
Alicia Vara-Vega
Silvia Vázquez
Esther Fuertes
Carmen Fernández-Criado
Manuel O Landázuri
Julián Aragonés
Hospital Universitario de La Princesa · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Von Hippel Lindau (Vhl) gene inactivation results in embryonic lethality. The consequences of its inactivation in adult mice, and of the ensuing activation of the hypoxia-inducible factors (HIFs), have been explored mainly in a tissue-specific manner. This mid-gestation lethality can be also circumvented by using a floxed Vhl allele in combination with an ubiquitous tamoxifen-inducible recombinase Cre-ER(T2). Here, we characterize a widespread reduction in Vhl gene expression in Vhl(floxed)-UBC-Cre-ER(T2) adult mice after dietary tamoxifen administration, a convenient route of administration that has yet to be fully characterized for global gene inactivation. Vhl gene inactivation rapidly resulted in a marked splenomegaly and skin erythema, accompanied by renal and hepatic induction of the erythropoietin (Epo) gene, indicative of the in vivo activation of the oxygen sensing HIF pathway. We show that acute Vhl gene inactivation also induced Epo gene expression in the heart, revealing cardiac tissue to be an extra-renal source of EPO. Indeed, primary cardiomyocytes and HL-1 cardiac cells both induce Epo gene expression when exposed to low O(2) tension in a HIF-dependent manner. Thus, as well as demonstrating the potential of dietary tamoxifen administration for gene inactivation studies in UBC-Cre-ER(T2) mouse lines, this data provides evidence of a cardiac oxygen-sensing VHL/HIF/EPO pathway in adult mice.

Indexed as

Gene SilencingAnimalsAnimals, NewbornBody WeightCells, CulturedDietErythropoietinGene Expression RegulationGlucose Transporter Type 1Hypoxia-Inducible Factor 1, alpha SubunitIntegrasesMiceMyocardiumMyocytes, CardiacOrgan SpecificityTamoxifenCre recombinaseErythropoietinGlucose Transporter Type 1Hypoxia-Inducible Factor 1, alpha SubunitIntegrasesSlc2a1 protein, mouseTamoxifenVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID21811636
PMCPMC3141062
OpenAlexW2017570840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.